Article Versions Notes

Temmoku J, Miyata M, Suzuki E, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Fujita Y, Matsuoka N, Asano T, et al. Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis. Journal of Clinical Medicine. 2023; 12(14):4585. https://doi.org/10.3390/jcm12144585

Temmoku, Jumpei, Masayuki Miyata, Eiji Suzuki, Yuya Sumichika, Kenji Saito, Shuhei Yoshida, Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, and et al. 2023. "Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis" Journal of Clinical Medicine 12, no. 14: 4585. https://doi.org/10.3390/jcm12144585

Temmoku, J., Miyata, M., Suzuki, E., Sumichika, Y., Saito, K., Yoshida, S., Matsumoto, H., Fujita, Y., Matsuoka, N., Asano, T., Sato, S., & Migita, K. (2023). Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis. Journal of Clinical Medicine, 12(14), 4585. https://doi.org/10.3390/jcm12144585